acf domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /home/care24/public_html/wp-includes/functions.php on line 6131
Momentum provides a range of high throughput mass spectrometry screening technologies to identify hits for small molecule inhibitors, degraders, covalent binders, PPI inhibitors, and those targeting RNA, followed by cell based chemoprotoemic assays to further probe signals of future clinical utility. This signaling information allows biopharma researchers to make better decisions when selecting and prioritizing compounds during discovery and preclinical development.
BILLERICA, MA, November 29, 2023. Momentum Biotechnologies, a leading provider of mass spectrometry-based analytical drug discovery services, has announced the launch of new services focused on proteomics. Offerings will include targeted and global proteomics, chemoproteomics and comparative proteomics using TMT-labelling […]
BILLERICA, MA, USA and MILAN, ITALY, November 15, 2023. Axxam S.p.A. and Momentum Biotechnologies have announced a partnership to provide unique drug discovery solutions for biotechnology and pharmaceutical clients. Through the partnership Axxam’s highly curated chemical diversity library, comprised of […]
BILLERICA, Mass., Sept. 13, 2023 /PRNewswire/ — Momentum Biotechnologies (“Momentum” or the “Company”), a leading contract research organization (“CRO”) specializing in mass spectrometry-based native detection technologies, is pleased to announce the appointment of Dr. Kevin Bateman to its Scientific Advisory Board. Dr. Bateman has 25+ years […]
BILLERICA, MA (Aug. 10, 2023) – Momentum Biotechnologies (“Momentum” or the “Company”), a leading contract research organization (“CRO”) specializing in mass spectrometry-based native detection technologies, is pleased to announce the appointment of Harvard Medical School Professor Dr. Ying Lu to its Scientific […]
© Care Equity Capital Management L.P. New York, New York
